Browsing by Author "Castagna, Luca"
Now showing items 1-9 of 9
-
Addition of rituximab in reduced intensity conditioning regimens for b-cell malignancies does not influence transplant outcomes: ebmt registry analyses following allogeneic stem cell transplantation for b-cell malignancies
Tomaszewska, Agnieszka; Jagasia, Madan; Beohou, Eric; et al.Frontiers in Immunology, 2020, 11, 613954Article dans une revue scientifiquefulltext -
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
Bazarbachi, Ali; Boumendil, Ariane; Finel, Herve; et al.Cancer, 01-01-2019, 125, 90-98Article dans une revue scientifiquefulltext -
Impact of spleen size and splenectomy on outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis: a retrospective analysis by the chronic malignancies working party on behalf of ebmt
Polverelli, Nicola; Mauff, Katya; Krger, Nicolaus; et al.American Journal of Hematology, 01-2021, 96, 69-79Article dans une revue scientifique -
Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a lwp-ebmt study
Bazarbachi, Ali; Boumendil, Ariane; Finel, Herve; et al.British Journal of Haematology, 03-2020, 188, 745-756Article dans une revue scientifique -
Nonmyeloablative alternative donor transplantation for hodgkin and non-hodgkin lymphoma: from the lwp-ebmt, eurocord, and cibmtr
Fatobene, Giancarlo; Rocha, Vanderson; St Martin, Andrew; et al.Journal of clinical oncology . official journal of the American Society of Clinical Oncology, 07-02-2020, JCO1902408Article dans une revue scientifique -
Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
Martinez, Carmen; Gayoso, Jorge; Canals, Carmen; et al.Journal of clinical oncology, 20-10-2017, 35, 3425-+Article dans une revue scientifique -
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT
Robinson S, P; Boumendil, Ariane; Finel, Herve; et al.Annals of oncology, 01-06-2016, 27, 1088-1094Article dans une revue scientifique -
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT.
Devillier, Raynier; Galimard, Jacques-Emmanuel; Labopin, Myriam; et al.Bone Marrow Transplantation, 26-06-2022, 57, 1421–1427Article dans une revue scientifique -
Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy
Gauthier, Jordan; Castagna, Luca; Garnier, Federico; et al.Bone marrow transplantation, 01-05-2017, 52, 689-696Article dans une revue scientifique